Page 70 - Aet News Today

Roche’s Telavant acquisition comes as the Roivant Sciences subsidiary prepares its main asset for Phase 3 testing in ulcerative colitis. The antibody drug candidate blocks a novel target for inflammation and fibrosis that’s also the focus of clinical-stage programs of other big pharma companies.

If the remaining 10 states expanded Medicaid, uninsured rates would greatly drop for women of reproductive age, non-Hispanic Black adults and young adults, a new Urban Institute report found.

There are several gaps in suicide prevention, including a lack of screening and access to care. During a recent panel discussion at HLTH 2023, execs detailed what gaps need to be filled.

A new study led by Stanford researchers tested four commercially available LLMs and found that they all could potentially cause harm by breeding inaccurate, racist information. For example, all models tried to justify race-based medicine when asked questions about calculating patients’ kidney function and lung capacity — two areas where race-based medicine practices used to be common but have since been scientifically refuted.

Weight loss company Calibrate — which sells a program combining GLP-1 drugs with personalized metabolic health coaching — announced a legal restructuring of its business. The startup, which had two major rounds of layoffs this year, has struggled in recent months amid GLP-1 drug shortages and mounting user complaints.

The FDA approved Pfizer’s Penbraya for vaccinating against five bacterial groups that can cause meningococcal disease. Pfizer already has vaccines covering those groups, but Penbraya addresses all of them in a single vaccine, making dosing easier for patients.

Patient safety and lack of autonomy are two of the biggest factors driving so many clinicians away from the medical field, according to a new EY report. Clinicians feel like they aren’t able to provide patients with the quality of care they need and deserve due to workforce shortages, resource constraints, and health system policies over which they have no control.

In submitted comments to the Departments of Health and Human Services, Treasury and Labor, AHIP argued that the proposed mental health parity rule would not expand access to mental health support. It believes the rule should be withdrawn altogether.

Access to oncology-specific interdisciplinary care delivered digitally by a team of nurses, mental health therapists, nutritionists, advanced practice providers, and oncologists is the best option for combatting pain points related to both cost and access.

The CDC calls for increased access to sexual health services and prioritization of STI screening and treatment, an all-hands attempt to turn the surge. So why hasn’t the American Medical Association (AMA),approved CPT codes for at-home STI testing and linkage to care services?